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doi:10.1016/j.ejvs.2010.11.034Abstract Objectives: This study aimed to determine the importance of the shear-stress-
sensitive calcium channels Trpc1, Trpm7, Trpp2, Trpv2 (transient receptor potential cation
channel, subfamily V, member 2) and Trpv4 for cerebral arteriogenesis. The expression profiles
were analysed, comparing the stimulation of collateral growth by target-specific drugs to that
achieved by maximum increased fluid shear stress (FSS).
Design: A prospective, controlled study wherein rats were subjected to bilateral carotid artery
ligature (BCL), or BCL þ arteriovenous fistula, or BCL þ drug application.
Methods: Messenger RNA (mRNA) abundance and protein expression were determined in FSS-
stimulated cerebral collaterals by quantitative real-time polymerase chain reaction (qRT-
PCR) and immunohistochemistry. Drugs were applied via osmotic mini pumps and arteriogen-
esis was evaluated by post-mortem angiograms and Ki67 immunostaining.
Results: Trpv4 was the onlymechanosensitive Trp channel showing significantly increasedmRNA
abundance and protein expression after FSS stimulation. Activation of Trpv4 by 4a-phorbol-
12,13-didecanoate caused significantly enhanced collateral growth (length: 4.43  0.20 mm
and diameter: 282.6  8.1 mm) compared with control (length: 3.80  0.06 mm and diameter:
237.3  5.3 mm). Drug application stimulated arteriogenesis to almost the same extent as did
maximum FSS stimulation (length: 4.61  0.07 mm and diameter: 327.4  12.6 mm).
Conclusions: Trpv4 showed significantly increased expression in FSS-stimulated cerebral collat-
erals. Pharmacological Trpv4 activation enhanced cerebral arteriogenesis, pinpointing Trpv4 as
a possible candidate for the development of new therapeutic concepts.
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590 W. Schierling et al.Introduction and stimulation of collateral growth by target-specificIn occlusive cerebrovascular disease, high-grade internal
carotid artery stenosis or even complete occlusion can be
compensated for by the circle of Willis.1e3 Adaptation of
the collateral circulation may be achieved by arterio-
genesis. This term applies to the remodelling of pre-exist-
ing arterio-arteriolar anastomoses or arteries outside the
ischaemic region, which can replace the capacity of a
larger artery.4e6As haemodynamic compromise due to
insufficient collateral flow is associated with an increased
risk of stroke or progressive brain ischaemia,1e3 new ther-
apeutic options to enhance cerebral arteriogenesis are of
considerable importance.
Busch et al. (2003) demonstrated that arteriogenesis can
be induced in the adult rat brain by establishing the three-
vessel occlusion (3-VO) model (occlusion of one carotid
artery and both vertebral arteries).7 One stimulating factor
of cerebral arteriogenesis is the granulocyte-macrophage
colony-stimulating factor (GM-CSF). In the 3-VO model,
subcutaneous application of GM-CSF led to significant
enlargement of the ipsilateral posterior cerebral artery
(PCA), a functional improvement of brain haemodynamic
parameters and a significant reduction of experimentally
induced stroke volume.8,9 Complete recovery of the cere-
brovascular reserve capacity has also been demonstrated
after long-term GM-CSF treatment in the bilateral carotid
artery occlusion (BCO) model.10 The proarteriogenic effect
of GM-CSF has been explained by the prolongation of the
life cycle of monocytes/macrophages, which are important
mediators of arteriogenesis.4,8e11
Recently, our group has provided evidence that the
pivotal trigger of cerebral arteriogenesis is increased
intravascular blood flow/fluid shear stress (FSS) and that
the growth of cerebral collaterals correlates with rising
intravascular flow rate.12 By analysing the two PCAs of the
circle of Willis, as important collaterals after BCO, we
demonstrated after 7 days, in the double-ligature model
(simultaneous ligature of both common carotid arteries)
that blood flow in the two PCAs increases up to 5.0-fold
and the diameter of the two PCAs up to 2.2-fold
(Fig. 1).12 A further increase of blood flow and, thereby,
vessel growth was reached by additional creation of an
arteriovenous (AV) fistula between the distal stump of the
occluded common carotid artery and the nearby jugular
vein on the left side (ligature-shunt model). In this model,
blood flow increased in the ‘shunt’-sided PCA up to 7.5-
fold and the diameter of the shunt-sided PCA up to 2.9-
fold after 7 days (Fig. 1).12
One factor involved in translating FSS into a molecular
pathway might be the transient receptor potential (TRP)
cation channels. These have been implicated in a broad
range of functions such as vasomotion, transducers of
mechanical, osmotic and thermal stimuli as well as vascular
smooth muscle cell (VSMC) proliferation.13e15
Thus, the aim of this study was to determine the
importance of the known shear-stress-sensitive calcium
channels Trpc1 (subfamily C, member 1), Trpm7 (subfamily
M, member 7), Trpp2 (subfamily P, member 2), Trpv2
(subfamily V, member 2) and Trpv4 (subfamily V, member
4)1315 for cerebral arteriogenesis. The expression profiledrugs compared with stimulation by maximally increased
FSS was, therefore, analysed. Mitochondrial RNA (mRNA)
and protein expression were detected in the shear-stress-
stimulated cerebral collateral circulation at different time
points. Drugs were applied via osmotic mini pumps, and the
resulting cerebral collateral growth was compared with the
high shear stress ligature-shunt model.
Materials and Methods
Animal models
The present study was performed with the permission of
the State of Hessen, according to Section 8 of the German
Law for the Protection of Animals and conforming to the
Guide of Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication No. 85-
23, revised 1996).
Surgical procedures were carried out under anaesthesia
with ketamine (100 mg kg1) and xylazine (4 mg kg1)
administrated i.p. To prevent pain, buprenorphine
(0.03 mg kg1) was applied.
Shear stress models
Sixty male SpragueeDawley rats (250e300 g; Charles River
Laboratories, Sulzfeld, Germany) were randomly assigned to
double-ligature, ligature-shunt and sham groups (n Z 20
each). Surgery was performed as previously described:12
bilateral ligature of the common carotid artery (double-
ligature) and bilateral ligature of the common carotid
artery þ AV fistula on the left side (ligature-shunt).12 Sham-
operated animals served as controls (Fig. 1). Cerebral integ-
rity of the animals after this surgical procedure has been
confirmed in previous studies by magnetic resonance
imaging.12
Osmotic mini pump models
Drugs were applied via osmotic mini pumps (Model 2001;
Alzet Osmotic Pumps, Distributor: Charles River Labora-
tories). The phorbol ester, 4a-phorbol-12,13-didecanoate
(4aPDD, 0.1 mg kg1 day1; SigmaeAldrich, Taufkirchen,
Germany), which is a direct, protein kinase C (PKC)-inde-
pendent channel modulator of N- and L-type Ca2þ-channels
and KATP-channels, was used for Trpv4 activation. This ester
has been proven to be a robust, reliable tool to study
features of Trpv channels and to probe functional effects of
channel activation in in vivo systems.16,17 The classic Trp
antagonist, Ruthenium Red (RuthRed, 1.0 mg kg1 day1;
SigmaeAldrich), which reversibly inhibits inward Trpv4
currents, was used to block the Trpv4-channel.16,17
Thirty-three male SpragueeDawley rats (250e300 g)
were outfitted with subcutaneously implanted osmotic mini
pumps connected to a catheter. After bilateral ligature of
the common carotid arteries, this catheter was positioned
in the distal stump of the left common carotid artery with
the tip next to the carotid bifurcation, so as not to hinder
collateral flow (Fig. 4(A)). Animals were randomly assigned
to solvent control, RuthRed (2 mg per pump), and 4aPDD
(200 mg per pump) groups (n Z 11 each).
Figure 1 Collateral growth in the rat brain after 7 days of shear stress-stimulation. Representative angioarchitecture of the rat
brain in sham-treated animals (A) and after bilateral ligature of the common carotid arteries (Double-Ligature; B) and bilateral
ligature of the common carotid arteries þ left-sided AV fistula creation (Ligature-Shunt; C). AV fistula (C): Arrow points towards the
end-to-side anastomosis between the distal stump of the occluded common carotid artery and the nearby jugular vein. PCA
(posterior cerebral artery), PComA (posterior communicating artery), ICA (internal carotid artery), MCA (middle cerebral artery),
CCA (common carotid artery).
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polymerase chain reaction (qRT-PCR)
After 1, 3 or 7 days of FSS stimulation, rats were euthanised
by bleeding after an overdose of ketamine. Total RNA was
isolated (RNeasy Micro Kit, Qiagen, Hilden, Germany) from
the posterior collateral circulation including both PCAs and
posterior communicating arteries and the basilar artery
(n Z 5 each at every point of time). After DNA digestion
with DNase-I (Turbo DNAfree, Ambion, Darmstadt,
Germany), complementary DNA (cDNA) was synthesised
according to Superscript II reverse transcriptase protocol
(Invitrogen, Karlsruhe, Germany) using 200 ng total RNA and
200 ng random nonamer oligonucleotides (New England
BioLabs Inc., Frankfurt am Main, Germany).
Gene-specific qRT-PCR primers were selected using
FastPCR software (Institute of Biotechnology, University of
Helsinki, Finland). qRT-PCR was performed in a 25-ml
reaction/96-well format using 1.0 ml cDNA (1:20), 200 nM
each primer, and 1 iQ SYBR Green Super Mix (Bio-Rad,
Laboratories, Mu¨nchen, Germany) in an iCycler RT-PCR
system (Bio-Rad Laboratories). Samples were measured in
triplicate, with a minimum of two independent experi-
ments. Relative amount of target mRNA normalised to 18S
RNA was calculated as previously described.18
Immunohistochemistry
For Trpv4 staining (shear stress models), rats were
euthanised 7 days after surgery (n Z 5) and for Ki67
staining (osmotic mini pump models), 3 and 5 days after
surgery (n Z 3 each, at every time point). Immunostainingof both PCAs and the basilar artery was performed on 5-mm
cryosections, as previously described.12
The following antibodies/agents were used: Trpv4
(1:100, Alomone Labs Ltd., Jerusalem, Israel), CD31 (1:100,
Antigenix America Inc., Huntington Station, NY, USA), Ki67/
MIB-5 (1:20, Dako, Hamburg, Germany); Biotin-SP-conju-
gated donkey anti-rabbit immunoglobulin G (IgG) (Dianova,
Hamburg, Germany), Cy2-conjugated Streptavidin (Bio-
trend, Ko¨ln, Germany), Cy3-conjugated anti-mouse IgG
(Chemicon/Millipore, Schwalbach, Germany), Phalloidin
fluorescein isothiocyanate (FITC) labelled (actin staining;
SigmaeAldrich) and Draq5 (nuclei staining; Alexis
Biochemicals, Lo¨rrach, Germany). Sections were viewed
with a confocal scanning laser microscope (Leica TCS SP),
as previously described.12
The quantification of Trpv4 fluorescence intensity was
performed with representative images, using ImageJ
1.38p software (http://rsb.info.nih.gov/ij/), as previ-
ously described.19 A full range of grey values, from black
to peak white (0-pixele255-pixel intensity level), was set
during measurements. Fluorescence intensity was
expressed as arbitrary units per square micrometre
(AU mm2). For determination of the proliferation index in
growing basilar arteries, Ki67-positive nuclei of endothe-
lial cells (ECs) and smooth muscle cells (SMCs) were
counted and referred to the total number of nuclei of
each particular vessel layer.
Cerebral post-mortem angiograms
Diameter and vessel length of both PCAs were analysed to
evaluate cerebral arteriogenesis after 7 days of treatment
592 W. Schierling et al.with RuthRed, 4aPDD and solvent control versus sham
(nZ 5 each), as previously described,12 and compared with
the collateral growth after 7 days of increased shear-stress
stimulation in the ligature-shunt model. Briefly, after
maximum adenosine-induced vasodilatation, the cerebro-
vascular circulation of euthanised rats was perfused with
prewarmed (37 C), gelatine/barium-based contrast
medium via the right carotid artery at a physiological
pressure of 80 mmHg. Pictures were taken using a digital
camera mounted on a Carl Zeiss microscope (OPMI 1 FR).
Vessel length was measured between stem and re-entry,
and external diameters at three different levels using
ImageJ 1.38p software (http://rsb.info.nih.gov/ij/).
Statistical analysis
Data are presented as mean  standard error of the mean
(SEM). The D’Agostino and Pearson omnibus normality test
was used to test normal distribution, group differences
were analysed for statistical significance using one-way
analysis of variance (ANOVA) and post hoc comparisons
were performed using a Bonferroni correction (Prism,
GraphPad Software, Inc.). A p value <0.05 was considered
statistically significant.Figure 2 Expression profile of known shear-stress-sensitive Trp-
mRNA-abundance of Trpc1 (A), Trpm7 (B), Trpp2 (C), Trpv2 (D), and
days of FSS stimulation in the Double-Ligature and Ligature-Shunt
numbers of transcripts were measured in fold-changes vs sham-
mean  SEM; *p < 0.05 vs sham; **p < 0.05.Results
Trpv4 is the only one of the known shear-stress-
sensitive Trp-channels with increased expression
on the transcriptional and translational levels
mRNA was isolated from the posterior collateral circulation
of the double-ligature and ligature-shunt groups (Fig. 1)
and qRT-PCR was performed for the known shear-stress-
sensitive Trp channels Trpc1, Trpm7, Trpp2, Trpv2 and
Trpv4 at 1,3 and 7 days after surgery (nZ 5 each, at every
time point; Fig. 2).
Evaluation of Trpc1, Trpm7, Trpp2 and Trpv2 failed to
demonstrate elevated mRNA levels after shear stress stimu-
lation in the double-ligature as well as in the ligature-shunt
group (Fig. 2(A)e(D)). By contrast, elevated expression of
Trpv4 mRNA versus sham-operated controls was found in the
double-ligature group on day 1 (2.3  0.2-fold), which
increased to 3.1 0.3-fold and 3.0 0.3-fold on days 3 and 7,
respectively (Fig. 2(E); p < 0.05). Even higher mRNA
expression was seen after further increased shear-stress
stimulation in the ligature-shunt groupup to 3.40.2-fold on
day 1 and,maximally, up to 4.8 0.5-fold on day 3 (Fig. 2(E);
p < 0.05 vs. control and double-ligature groups).channels in the FSS-stimulated cerebral collateral circulation.
Trpv4 (E) in the posterior collateral circulation after 1, 3, and 7
group using qRT-PCR (nZ 5 each at every time point). Relative
treated controls (Z 1, black line). Values are expressed as
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double-ligature and ligature-shunt groups at day 7 to
further localise Trpv4 protein expression in the vessel wall
(n Z 5 each; Fig. 3).
Basal Trpv4 protein expression was detected in the
vessel wall of sham-operated controls (Fig. 3(A) and (B)).
Distinctly increased Trpv4 protein expression, restricted to
the endothelium, was determined in ligature-treated PCAs
(8.4  1.5 AU mm2 ligature vs. 2.0  0.9 AU mm2 sham;
p < 0.05; Fig. 3(A)e(B)). Maximal fluorescence-intensity for
Trpv4-protein expression in the endothelium was found
after maximal shear-stress stimulation at the ‘shunt’-sided
PCA of the ligature-shunt group (19.4  4.7 AU mm2;
p < 0.05 vs. sham and ligature groups; Fig. 3(A) and (B)).
Cerebral arteriogenesis is considerably enhanced
by pharmacological activation of the
mechanosensitive calcium channel Trpv4
Trpv4 activity was modulated in vivo after bilateral
carotid ligature by additional application of 4aPDD or
RuthRed via osmotic mini pumps for a period of 7 days
(bilateral carotid artery ligature (BCL) þ drug application;
Fig. 4(A)). 4aPDD is a non-PKC-activating phorbol ester
and a subtype-selective Trpv4 agonist of Trpv4. The classicFigure 3 Shear stress-sensitive response of Trpv4 protein-expre
taining of the posterior cerebral arteries after 7 days of FSS stimulat
to sham-treated controls. Representative images: Trpv4: green; C
fication of fluorescence-intensity, given in arbitrary units (AU)
mean  SEM; n Z 5 each; *p < 0.05 vs sham; **p < 0.05.Trp inhibitor, Ruthenium Red, reversibly inhibits inward
but not outward Trpv4 currents and is also an antagonist
of other Trpv channels. The resulting impact on cerebral
arteriogenesis was compared with the high shear stress,
ligature-shunt model (BCL þ left-sided AV fistula). To
quantify cerebral arteriogenesis, length and diameter of
the PCAs were determined by post-mortem angiograms
after maximum adenosine-induced vasodilatation (n Z 5
each; Fig. 4). The normal angioarchitecture of the unsti-
mulated PCAs is shown in sham-operated animals (Fig. 4
(B) and (C)).
Analysis of the length of the PCAs showed a significant
increase after 7 days of 4aPDD treatment versus solvent
control (4.43  0.20 vs. 3.80  0.06 mm; p < 0.05; Fig. 4(B)
and (C)). The increase almost reached the same level as
that achievedafter ‘shunt’ treatment (4.610.07mm;Fig. 4
(B) and (C)). Treatmentwith RuthRed significantly decreased
vessel length comparedwith solvent control (3.38 0.09mm
vs. 3.80  0.06 mm; p < 0.05; Fig. 4(B) and (C)).
Cerebral arteriogenesis, assessed by vessel diameter,
was significantly enhanced by 4aPDD treatment compared
with solvent control (282.6  8.1 mm vs. 237.3  5.3 mm;
p < 0.05; Fig. 4(B) and (C)). However, values as high as
those reached after ‘shunt’ treatment were not achieved
(327.4  12.6 mm; p < 0.05; Fig. 4(B) and (C)). Treatmentssion in the posterior cerebral arteries. (A), Trpv4-immunos-
ion in the Double-Ligature and Ligature-Shunt group compared
D31 (endothelial cells): red; Draq5 (nuclei): blue. (B), Quanti-
/mm2, by ImageJ 1.38p software. Values are expressed as
Figure 4 Influence of 4aPDD-/RuthRed-treatment on cerebral arteriogenesis after 7 days. (A), Schematic diagram of the osmotic
mini pump model. ICA (internal carotid artery), ECA (external carotid artery), CCA (common carotid artery), PComA (posterior
communicating artery), PCA (posterior cerebral artery). (B), Representative images of the posterior cerebral arteries (PCAs) after
bilateral carotid ligature (BCL) þ 7 days of 4aPDD- or RuthRed-treatment vs Solvent Control and compared to sham- and Ligature-
Shunt-operated animals. Arrows point towards the posterior cerebral arteries. (C), Quantitative analysis of post-mortem angiograms
on vessel length and diameter of the posterior cerebral arteries after BCL þ 7 days of 4aPDD- or RuthRed-treatment vs Solvent
Control, compared to sham- and Ligature-Shunt-operated animals. Values are expressed as mean  SEM; *p < 0.05; nZ 5 each.
594 W. Schierling et al.with RuthRed showed only a trend to reduce vessel diam-
eter in comparison to solvent control (Fig. 4(B) and (C)).
Ki67 immunostaining of the A. basilaris was performed
after 3 and 5 days of 4aPDD- or RuthRed treatment to
monitor the proliferation activity of ECs and SMCs in vivo
(nZ 3 each at every point of time; Fig. 5). The left panel in
Fig. 5(A) and (B) demonstrates the normal proliferation of
vascular cells in the unstimulated basilar artery of sham-
operated animals (Fig. 5(A)e(C)).
Proliferation activity of the ECs (from day 3) and SMCs
(from day 5) was significantly increased after Trpv4 acti-
vation by 4aPDD compared with solvent control. Applica-
tion of RuthRed significantly decreased proliferation
activity of vascular cells (Fig. 5(A)e(C): ECs on day 3:
70.5  1.5% 4aPDD vs. 31.3  5.3% solvent control vs.
8.0  4.5% RuthRed; ECs on day 5: 38.4  5.2% 4aPDD vs.
16.9  2.5% solvent control vs. 9.5  2.7% RuthRed; SMCs on
day 5: 13.0  3.6% 4aPDD vs. 5.5  2.1% solvent control vs.
5.8  2.5% RuthRed; p < 0.05).Discussion
Insufficient cerebral collateral blood flow increases the risk of
stroke or progressive brain ischaemia.1e3 Therefore, it is
important to establish new therapeutic options to enhance
collateral growth in the brain. In previous studies, we have
demonstrated that FSS is the pivotal trigger of cerebral arte-
riogenesis.12 Consequently, tracing the molecular pathway of
increased FSS could open an avenue to pharmacological
enhancement of cerebral arteriogenesis. Relevant candidates
are the TRP cation channels, which are expressed in almost
every tissue, including the heart and vasculature.20 Most of
the 28mammalian Trp channels are permeable to Ca2þ, act as
multifunctional cellular sensors and are involved in funda-
mental cell functions such as contraction, proliferation and
cell death.20 Hence, the subject of this study was to investi-
gate theknownshear-stress-sensitivecalciumchannelsTrpc1,
Trpm7, Trpp2, Trpv2 and Trpv4,1315 and evaluate their
importance for cerebral arteriogenesis.
Figure 5 Proliferation activity in cerebral collaterals after 4aPDD-/RuthRed-treatment. Ki67-immunostaining of the basilar
artery after bilateral carotid ligature (BCL) þ 3 days (A) and 5 days (B) of 4aPDD- and RuthRed-treatment vs Solvent Control,
compared to sham-operated animals. Representative images: Ki76: red, Phalloidin-FITC (actin): green, Draq5 (nuclei): blue. (C),
Proliferation activity of endothelial and smooth muscle cells in the basilar artery after BCL þ 3 days and 5 days of 4aPDD-
and RuthRed-treatment vs Solvent Control, compared to sham-operated animals (black line). Values are expressed as mean  SEM;
*p < 0.05; n Z 3 each, at both time points.
Trpv4 Activation Enhances Cerebral Arteriogenesis 595Smooth muscle and endothelium are remarkably diverse,
with major structural and functional heterogeneity
apparent between organs and along vascular segments.20 So
far, little is known about how this diversity is maintained
and how site-specific responses are determined.20 In the
present study, Trpv4 was the only one of the known
mechanosensitive Trp channels with increased mRNA and
protein expression after shear-stress stimulation.
In accordance with other studies,15 we found Trpv4
highly expressed in endothelial cells. Moreover, the
expression of the Trpv4 protein in the endothelium was
highly shear stress-sensitive. Therefore, insufficient adap-
tation to occlusion or stenosis may lie in premature nor-
malisation of FSS, due to the fact that increasing collateral
diameter reduces FSS by the third power of the radius.21
This effect, which could not be fully compensated for
despite AV fistula creation, might account for decreasing
Trpv4 mRNA levels at 7 days after surgery, as opposed tohigher levels after 3 days. A relevant new finding of the
present study is that cerebral arteriogenesis can be signif-
icantly enhanced, not only by FSS, but also pharmacologi-
cally by application of 4aPDD. Compared with maximum
AV-fistula-induced FSS stimulation,12 the number of prolif-
erating ECs after 4aPDD treatment was even higher.
The increase of vessel length and diameter reached
approximately 86e96% of the maximum values achieved
after shunt-treatment. An explanation for the submaximal
4aPDD stimulation of arteriogenesis, compared with FSS
stimulation, is that mechanical FSS may stimulate addi-
tional pathways such as NO signalling,22,23 which remain
unstimulated by 4aPDD. The incomplete growth inhibition
by Ruthenium Red might be due to the fact that it is not
a specific Trpv4 antagonist, but also inhibits mitochondrial
Ca2þ-uniporter and other Trpv channels.13e15
The importance of Trpv4 and the possibility of pharmaco-
logical activation has been established in previous studies on
596 W. Schierling et al.peripheral arteriogenesis.19,24 This is relevant because there
are major differences in physiology, anatomy and morphology
betweencerebralandperipheralcollaterals.20Thedifferences
are reflected in low-resistance vessels in the brain versus high-
resistance vessels in the hindlimb and the number of visible
collaterals. Experiments have shown that two of the most
highly expressed genes in peripheral arteriogenesis, namely
the cardiac ankyrin repeat protein and the actin-binding Rho
activating protein,22 were not upregulated in cerebral arte-
riogenesis after shear-stress stimulation (unpublished data).
This highlights the calcium channel Trpv4 as a drug target of
special interest in developing new therapeutic concepts.
Downstream signalling, in particular Ca2þ-dependent
transcriptional activity of TRPV4 activation, has previously
been studied. Threemajor calcium-dependent transcriptional
effectors (nuclear factor of activated T-cells (NFAT), myocyte
enhancer factor2 (MEF2) and CSEN) as well as CaN, activator
protein-1 (AP-1) and CSEN are modulated during 4aPDD-trig-
gered or AV-shunt-induced peripheral arteriogenesis in pigs.24
One limitation of the present study is that functional
investigations on the cerebral haemodynamic reserve
capacity were not determined. Another limitation is that
4aPDD cannot be used for human patients. However, this is
the first demonstration of the importance of the shear-stress-
sensitive calcium channel Trpv4 for cerebral arteriogenesis.
Conclusions
The endothelially expressed and highly shear-stress-sensi-
tive Trpv4 calcium channel has proven to be an important
factor in the remodelling of collaterals during cerebral
arteriogenesis. Pharmacological activation of Trpv4 can
enhance cerebral arteriogenesis. Trpv4, as an endothelial
membrane-bound protein, may be an interesting new
target for the development of new therapeutic concepts in
treating cerebrovascular disease.
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